{"product_id":"cst-3207t","title":"CST,  3207T, AMACR (2A10) Mouse Monoclonal Antibody","description":"Monoclonal Antibody for studying AMACR. Validated for Western Blotting. Available in 2 sizes. Highly specific and rigorously validated in-house, AMACR (2A10) Mouse Monoclonal Antibody (CST #3207) is ready to ship.\n\n\u003cb\u003eProduct Usage Information\u003c\/b\u003e\nWestern Blotting: 1:1000\n\u003cb\u003eStorage\u003c\/b\u003e\nSupplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg\/ml BSA, 50% glycerol and less than 0.02% sodium azide. Store at -20°C. Do not aliquot the antibody.\n\u003cb\u003eProtocol\u003c\/b\u003e\nAvailable protocols: Western Blotting\n\u003cb\u003eSpecificity \/ Sensitivity\u003c\/b\u003e\nAMACR (2A10) Mouse Monoclonal Antibody detects endogenous levels of total AMACR protein.\nSpecies Reactivity: Human, Mouse\n\u003cb\u003eSource \/ Purification\u003c\/b\u003e\nMonoclonal antibody is produced by immunizing animals with a purified truncated recombinant human AMACR-His fusion protein.\n\u003cb\u003eBackground\u003c\/b\u003e\nα-Methylacyl-CoA racemase (AMACR), an enzyme localized in peroxisomes and mitochondria, is involved in the β-oxidation of branched-chain fatty acids and fatty acid derivatives (1). AMACR has been reported to be a biomarker for prostate cancer (2-4). AMACR expression is also related to other types of cancers, such as hepatocellular carcinoma (1), noninvasive bladder cancer (5), colorectal cancer (6), and gastric adenocarcinoma (7).\n\u003cb\u003eAlternate Names\u003c\/b\u003e\n2-methylacyl-CoA racemase; Alpha-methylacyl-CoA racemase; AMACR; AMACRD; CBAS4; P504S; RACE; RM\n\n\u003cb\u003eSpecification\u003c\/b\u003e\n\nREACTIVITY: H M\nSENSITIVITY: Endogenous\nMW (kDa): 42\nSource\/Isotype: Mouse IgG2b","brand":"CST","offers":[{"title":"Default Title","offer_id":46800971628713,"sku":"3207T","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/cst-3207t","provider":"Iright","version":"1.0","type":"link"}